Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy (2024)

Peer-Reviewed Study · Wei L, Ma Y, Ren Y, et al. · November 4, 2024

Wei L et al., 2024-11-04: Mouse and cell study finding methylene blue is strongly virucidal outside cells but does not inhibit intracellular replication and gave no antiviral efficacy in a lethal coronavirus mouse model. Cuts against the therapeutic reading of the antiviral claim.

Methylene blue demonstrated strong virucidal activity but did not inhibit viral replication in cells. The control compound nirmatrelvir lacked virucidal activity but exhibited strong abilities to inhibit viral replication.

Wei L et al., 2024-11-04: Mouse and cell study finding methylene blue is strongly virucidal outside cells but does not inhibit intracellular replication and gave no antiviral efficacy in a lethal coronavirus mouse model. Cuts against the therapeutic reading of the antiviral claim. Study type: in vitro plaque-reduction and cell-infection assays plus a lethal mouse model (CAG-hACE2 transgenic mice, SARS-CoV-2-related pangolin coronavirus GX_P2V). N not stated in abstract. Country: China (Beijing University of Chemical Technology). MB concentration not stated in abstract; extracellular virucidal EC50 rose in mouse plasma. Funding: NSFC-MFST China-Mongolia project and State Key Laboratory of Pathogen and Biosecurity. Conflicts: none declared. Comparator: nirmatrelvir. Also filed as MTL-047 (claims C1, C3). Study type: animal.